BL-B01D1
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), EGFR
Related Pathways
Angiogenesis, JAK/STAT signaling, Antibody-drug Conjugate/ADC Related, Tyrosine Kinase/Adaptors
Bioactivity
BL-B01D1 is a bispecific ADC that targets EGFR and HER3 via the bispecific antibody Izalontamab. It exerts cytotoxic effects on various cancer cells by using its ADC toxin ED04 to inhibit DNA replication and synthesis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
220-20S3 300 Units/Case
Filcons (disposable cell strainer cup type, 300 units) range between 10 and 500 um STERILE
Sign In for Pricing
View Details 
10555064 1.0 µg DNA
4632434I11Rik Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details